J. M. Adams, A. W. Harris, C. A. Pinkert, L. M. Corcoran, W. S. Alexander et al., The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice, Nature, vol.77, issue.6046, pp.533-538, 1985.
DOI : 10.1038/318533a0

P. Armand, A. Nagler, E. A. Weller, S. M. Devine, D. E. Avigan et al., Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial, Journal of Clinical Oncology, vol.31, issue.33, 2013.
DOI : 10.1200/JCO.2012.48.3685

S. Asakura, D. Hashimoto, S. Takashima, H. Sugiyama, Y. Maeda et al., Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice, Journal of Clinical Investigation, vol.120, issue.7, pp.2370-2378, 2010.
DOI : 10.1172/JCI39165

C. L. Bennett, F. Fallah-arani, T. Conlan, C. Trouillet, H. Goold et al., Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin, Blood, vol.117, issue.26, pp.7063-7069, 2011.
DOI : 10.1182/blood-2011-01-329185

B. R. Blazar, B. M. Carreno, A. Panoskaltsis-mortari, L. Carter, Y. Iwai et al., Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism, J, 2003.

C. Bourgeois, B. Rocha, and C. Tanchot, A Role for CD40 Expression on CD8+ T Cells in the Generation of CD8+ T Cell Memory, Science, vol.297, issue.5589, pp.2060-2063, 2002.
DOI : 10.1126/science.1072615

J. R. Brahmer, C. G. Drake, I. Wollner, J. D. Powderly, J. Picus et al., Phase I study of singleagent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical specific for the programmed death-1 homolog prevents graft-versus-host disease in mouse models, J. Immunol. Baltim. Md, vol.187, pp.1537-1541, 1950.

B. Flutter, N. Edwards, F. Fallah-arani, S. Henderson, J. Chai et al., Nonhematopoietic antigen blocks memory programming of alloreactive CD8+ T cells and drives their eventual exhaustion in mouse models of bone marrow transplantation, Journal of Clinical Investigation, vol.120, issue.11, pp.3855-3868, 2010.
DOI : 10.1172/JCI41446DS1

E. Goulmy, A. Termijtelen, B. A. Bradley, and J. J. Van-rood, Y-antigen killing by T cells of women is restricted by HLA, Nature, vol.4, issue.5602, pp.544-545, 1977.
DOI : 10.1038/262795a0

E. Goulmy, R. Schipper, J. Pool, E. Blokland, J. H. Falkenburg et al., Mismatches of Minor Histocompatibility Antigens between HLA-Identical Donors and Recipients and the Development of Graft-Versus-Host Disease after Bone Marrow Transplantation, New England Journal of Medicine, vol.334, issue.5, pp.281-285, 1996.
DOI : 10.1056/NEJM199602013340501

A. Gratwohl, H. Baldomero, M. Gratwohl, M. Aljurf, L. F. Bouzas et al., Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study, Haematologica, vol.98, issue.8, pp.1282-1290, 2013.
DOI : 10.3324/haematol.2012.076349

G. Guarda, M. Hons, S. F. Soriano, A. Y. Huang, R. Polley et al., L-selectin-negative CCR7??? effector and memory CD8+ T cells enter reactive lymph nodes and kill dendritic cells, Nature Immunology, vol.440, issue.7, 2007.
DOI : 10.1038/ni1469

O. Hamid, C. Robert, A. Daud, F. S. Hodi, W. Hwu et al., Safety and Tumor Responses with Lambrolizumab (Anti???PD-1) in Melanoma, New England Journal of Medicine, vol.369, issue.2, pp.134-144, 2013.
DOI : 10.1056/NEJMoa1305133

A. Pawarode, G. Yanik, and J. E. Levine, Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes, Haematologica, vol.98, pp.179-184, 2013.

T. Honda, J. G. Egen, T. Lämmermann, W. Kastenmüller, P. Torabi-parizi et al., Tuning of Antigen Sensitivity by T Cell Receptor-Dependent Negative Feedback Controls T Cell Effector Function in Inflamed Tissues, Immunity, vol.40, issue.2, pp.235-247, 2014.
DOI : 10.1016/j.immuni.2013.11.017

M. M. Hufford, T. S. Kim, J. Sun, and T. J. Braciale, T cell effector activities in situ are regulated by target cell type, The Journal of Experimental Medicine, vol.154, issue.1, pp.167-180, 2011.
DOI : 10.1016/S0002-9440(10)63950-8

I. Klein, C. , and I. N. , T cells activated locally within the transplanted liver, The Journal of Experimental Medicine, vol.52, issue.2, pp.437-447, 2006.
DOI : 10.4049/jimmunol.172.9.5222

W. Koestner, M. Hapke, J. Herbst, C. Klein, K. Welte et al., PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cells, Blood, vol.117, issue.3, pp.1030-1041, 2011.
DOI : 10.1182/blood-2010-04-283119

M. Tahar, D. Santo, J. P. Eberl, and G. , In vivo equilibrium of proinflammatory IL- 17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells, J. Exp. Med, vol.205, pp.1381-1393, 2008.
URL : https://hal.archives-ouvertes.fr/pasteur-00509619

D. C. Tscharke, A. G. Brooks, and T. Gebhardt, Distinct APC subtypes drive spatially segregated CD4+ and CD8+ T-cell effector activity during skin infection with HSV-1, PLoS Pathog, vol.10, 2014.

C. Matte-martone, S. Venkatesan, H. S. Tan, I. Athanasiadis, J. Chang et al., Graft-versus-Leukemia (GVL) against Mouse Blast-Crisis Chronic Myelogenous Leukemia (BC-CML) and Chronic-Phase Chronic Myelogenous Leukemia (CP-CML): Shared Mechanisms of T Cell Killing, but Programmed Death Ligands Render CP-CML and Not BC-CML GVL Resistant, The Journal of Immunology, vol.187, issue.4, 2011.
DOI : 10.4049/jimmunol.1100311

U. H. Andrian and . Von, Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation, Immunity, vol.25, pp.129-141, 2006.

E. P. Alyea and C. Cutler, Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission, Blood, vol.105, pp.2973-2978, 2005.

H. Nakasone, L. Tian, B. Sahaf, T. Kawase, K. Schoenrock et al., Allogeneic HY antibodies detected 3 months after female to male sex-mismatched HCT predict chronic GVHD and non-relapse mortality, Blood, 2015.

W. J. Norde, F. Maas, W. Hobo, A. Korman, M. Quigley et al., PD-1/PD-L1 Interactions Contribute to Functional T-Cell Impairment in Patients Who Relapse with Cancer After Allogeneic Stem Cell Transplantation, Cancer Research, vol.71, issue.15, pp.5111-5122, 2011.
DOI : 10.1158/0008-5472.CAN-11-0108

M. Pasquini, Z. Wang, M. M. Horowitz, and R. P. Gale, 2013 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders, 2013.

R. Sackstein, A Revision of Billingham???s Tenets: The Central Role of Lymphocyte Migration in Acute Graft-versus-Host Disease, Biology of Blood and Marrow Transplantation, vol.12, issue.1, p.27, 2006.
DOI : 10.1016/j.bbmt.2005.09.015

A. Saha, K. Aoyama, P. A. Taylor, B. H. Koehn, R. G. Veenstra et al., Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality, Blood, vol.122, issue.17, pp.3062-3073, 2013.
DOI : 10.1182/blood-2013-05-500801

K. Schilbach, J. Schick, M. Wehrmann, G. Wollny, P. Simon et al., PD-1???PD-L1 Pathway Is Involved in Suppressing Alloreactivity of Heart Infiltrating T Cells During Murine GVHD Across Minor Histocompatibility Antigen Barriers, Transplantation, vol.84, issue.2, pp.214-222, 2007.
DOI : 10.1097/01.tp.0000268074.77929.54

D. Schneidawind, A. Pierini, and R. S. Negrin, Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation, Blood, vol.122, issue.18, pp.3116-3121, 2013.
DOI : 10.1182/blood-2013-08-453126

E. I. Sega, D. B. Leveson-gower, M. Florek, D. Schneidawind, R. H. Luong et al., Role of Lymphocyte Activation Gene-3 (Lag-3) in Conventional and Regulatory T Cell Function in Allogeneic Transplantation, PLoS ONE, vol.186, issue.1, p.86551, 2014.
DOI : 10.1371/journal.pone.0086551.g007

J. C. Shand, H. Qin, N. Nasholm, C. M. Capitini, and T. J. Fry, Minor Antigen Distribution Predicts Site-Specific Graft-versus-Tumor Activity of Adoptively Transferred, Minor Antigen-Specific CD8 T Cells, Biology of Blood and Marrow Transplantation, vol.20, issue.1, pp.26-36, 2014.
DOI : 10.1016/j.bbmt.2013.10.009

H. Shimizu, T. Saitoh, N. Hatsumi, S. Takada, H. Handa et al., Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia, Leukemia Research, vol.37, issue.11, pp.1477-1481, 2013.
DOI : 10.1016/j.leukres.2013.08.017

E. F. Tewalt, J. N. Cohen, S. J. Rouhani, C. J. Guidi, H. Qiao et al., Lymphatic endothelial cells induce 28, 2012.

G. Tiegs and A. W. Lohse, Immune tolerance: What is unique about the liver, Journal of Autoimmunity, vol.34, issue.1, 2010.
DOI : 10.1016/j.jaut.2009.08.008

T. Toubai, I. Tawara, Y. Sun, C. Liu, E. Nieves et al., Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells, Blood, vol.119, issue.16, pp.3844-3853, 2012.
DOI : 10.1182/blood-2011-10-384057

A. Valujskikh, O. Lantz, S. Celli, P. Matzinger, and P. S. Heeger, Cross-primed CD8+ T cells mediate graft rejection via a distinct effector pathway, Nature Immunology, vol.3, issue.9, pp.844-851, 2002.
DOI : 10.1038/ni831

R. G. Veenstra, P. A. Taylor, Q. Zhou, A. Panoskaltsis-mortari, M. Hirashima et al., Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells, Blood, vol.120, issue.3, pp.682-690, 2012.
DOI : 10.1182/blood-2011-10-387977

K. Vincent, D. Roy, and C. Perreault, Next-generation leukemia immunotherapy, Blood, vol.118, issue.11, pp.2951-2959, 2011.
DOI : 10.1182/blood-2011-04-350868

K. Wilhelm, J. Ganesan, T. Müller, C. Dürr, M. Grimm et al., Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R, Nature Medicine, vol.16, issue.12, pp.1434-1438, 2010.
DOI : 10.1038/nm.2242

B. H. Zinselmeyer, S. Heydari, C. Sacristán, D. Nayak, M. Cammer et al., PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis, The Journal of Experimental Medicine, vol.121, issue.4, pp.757-774, 2013.
DOI : 10.1016/S0076-6879(09)05416-0